Advanced Solid Tumors
Showing 9976 - 10000 of >10,000
APAC, ASAP and GALAD Scores in Hepatocellular Carcinoma Among
Not yet recruiting
- Hepatocellular Carcinoma
- serum sample for ELIZA
-
Sohag, EgyptSohag University Hospital
Feb 12, 2023
Gastric Cancer, Gastroesophageal Junction Cancer Trial in China (Pembrolizumab, Placebo, Cisplatin)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Cancer
- Pembrolizumab
- +7 more
-
Beijing, Beijing, China
- +12 more
Aug 17, 2022
Blood, Urine and Bone Marrow of Patients With Solid Cancers
Recruiting
- Non-small Cell Lung Cancer
- +5 more
- Study sample collection
-
Columbia, MissouriEllis Fischel Cancer Center, University of Missouri
Dec 1, 2021
Metastatic Renal Cell Carcinoma Trial in Milan (Cabometyx)
Completed
- Metastatic Renal Cell Carcinoma
-
Milan, ItalyFondazione IRCCS Istituto Nazionale Tumori
Apr 23, 2021
Oligoprogressive, Castration-Resistant Prostate Cancer Trial in Toronto (Stereotactic Body Radiation Therapy (SABR))
Recruiting
- Oligoprogressive
- Castration-Resistant Prostate Cancer
- Stereotactic Body Radiation Therapy (SABR)
-
Toronto, Ontario, CanadaOdette Cancer Centre
Apr 9, 2021
Transbronchial Biopsy Assisted by Robot Guidance in Evaluation
Recruiting
- Pulmonary Nodule
- Lung Cancer
- Robotic assisted bronchoscopy
-
Scottsdale, Arizona
- +18 more
Jan 23, 2023
Advanced Cancer Trial in Edmonton, Fort McMurray, Grande Prairie (Advanced Cancer Support in Virtual Rehabilitation and
Recruiting
- Advanced Cancer
- Advanced Cancer Support in Virtual Rehabilitation and Exercise
-
Edmonton, Alberta, Canada
- +2 more
Apr 11, 2022
HCC, NSCLC Stage IIIB, NSCLC Stage IV Trial in Worldwide (YH001 + Toripalimab)
Not yet recruiting
- HCC
- +2 more
- YH001 + Toripalimab
-
Canton, Ohio, Armenia
- +21 more
Jul 20, 2022
Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])
Completed
- Hepatitis B, Chronic
- peginterferon alfa-2a [Pegasys]
-
San Francisco, California
- +38 more
Oct 26, 2022
Perception of COVID-19 Pandemic in Haematological or Solid
Unknown status
- Covid19
- questionnaire
-
Innsbruck, Tyrol, AustriaMedical University of Innsbruck
Nov 30, 2020
EMT on CTCs and Disease Progression in Prostate Cancer
Active, not recruiting
- Prostate Cancer
- CellSearch CTC platform
- Parsortix CTC platform
-
London, Ontario, CanadaLondon Regional Cancer Program
Mar 5, 2022
Correlation Between SPECT/CT and IDH Mutation in Brain Glioma
Not yet recruiting
- Brain Glioma
- (no location specified)
Oct 23, 2022
Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)
Not yet recruiting
- Small Cell Lung Cancer Extensive Stage
- quaratusugene ozeplasmid
- atezolizumab
- (no location specified)
Jan 19, 2023
Epstein-Barr Virus Positive, Gastric Adenocarcinoma, Mismatch Repair Protein Deficiency Trial in New Brunswick (drug, other,
Recruiting
- Epstein-Barr Virus Positive
- +10 more
- Capecitabine
- +3 more
-
Atlanta, Georgia
- +2 more
Dec 10, 2022
Gastric Cancer Trial in Wuhan (DC, concurrent chemoradiotherapy with 5-FU/CF, radiation)
Recruiting
- Gastric Cancer
- DC
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jan 29, 2022
Ovarian Cancer Trial in Roma (Blood samples)
Not yet recruiting
- Ovarian Cancer
- Blood samples
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 3, 2023
Ovarian Cancer, Serous Ovarian Cancer Trial in Pittsburgh (Regorafenib, Fulvestrant)
Not yet recruiting
- Ovarian Cancer
- Serous Ovarian Cancer
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer Institute
Apr 17, 2022
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023
Solid Cancer Trial in Guangzhou (TSA-CTL, Cyclophosphamide, Fludarabine)
Unknown status
- Solid Cancer
- TSA-CTL
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Jan 29, 2019
Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)
Not yet recruiting
- Hepatocellular Carcinoma
- Atezolizumab and Bevacizumab
- Y90 + TKI
-
Chicago, IllinoisNorthwestern University
Nov 11, 2022
Breast Cancer Trial in United States (Capecitabine, Neratinib, EORTC QLQ - BR23, EQ-5D-5L, EORTC QLQ-C30)
Active, not recruiting
- Breast Cancer
- Capecitabine
- +2 more
-
Hartford, Connecticut
- +9 more
Apr 15, 2022
Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast Cancer Trial in Changsha, Xiangyang (AK117,
Recruiting
- Metastatic Triple-negative Breast Cancer
- Locally Advanced Triple-negative Breast Cancer
- AK117
- +3 more
-
Changsha, China
- +1 more
Sep 8, 2022
GIST, Malignant, CBT Trial in Pittsburgh (MAAT)
Recruiting
- GIST, Malignant
- CBT
- MAAT
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Apr 15, 2022
Esophageal Cancer, Squamous Cell Esophagus Cancer, Adenocarcinoma Esophagus Trial in Boston (Pembrolizumab)
Active, not recruiting
- Esophageal Cancer
- +2 more
-
Boston, Massachusetts
- +2 more
Apr 7, 2022
A Chart Review Study of Adults With Advanced NSCLC
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- (no location specified)
Aug 1, 2022